EFL074 - Taking Levothyroxine Fasting vs. With Breakfast
Artikelen konden niet worden toegevoegd
De titel kon niet aan de winkelwagen worden toegevoegd.
De titel kon niet aan de verlanglijst worden toegevoegd.
Verwijderen van verlanglijst mislukt
'Podcast volgen' mislukt
“Podcast niet meer volgen” mislukt
-
Verteld door:
-
Van:
For our 74th episode, recorded live at ENDO 2026 in Chicago, we review a recent JCEM study that addresses a common clinical question: does levothyroxine need to be taken on an empty stomach?
This randomized clinical trial evaluates a dose-adjusted, non-fasting regimen and finds that a 15% increase with breakfast ingestion achieves TSH stability similar to that with standard fasting dosing. The results also suggest potential improvements in adherence and patient-reported well-being, while highlighting variability in dose adjustments and limitations in generalizability.
Host Chase Hendrickson, MD, MPH, MHCC, from Vanderbilt University, is joined by regular contributor Andy Crawford, MD, from Dartmouth-Hitchcock Medical Center, and guest expert Matt Edelson, MD, from the University of Chicago. Together, they discuss “Fasting versus non-fasting dose-adjusted levothyroxine ingestion in hypothyroidism,” published in the April 2026 issue of JCEM, and consider how these findings may inform patient-centered approaches to medication timing and management.